Combination of palbociclib and radiotherapy for glioblastoma

The cyclin-dependent kinase inhibitor, palbociclib has shown compelling efficacy in breast cancer patients. Several pre-clinical studies of glioblastoma (GBM) have also shown palbociclib to be efficacious. In this study, we investigated palbociclib in combination with radiation therapy (RT) for trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Whittaker, Shane, Madani, Daniel, Joshi, Swapna, Chung, Sylvia A, Johns, Terrance, Day, Bryan, Khasraw, Mustafa, McDonald, Kerrie L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494656/
https://www.ncbi.nlm.nih.gov/pubmed/28690875
http://dx.doi.org/10.1038/cddiscovery.2017.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494656/
https://www.ncbi.nlm.nih.gov/pubmed/28690875
http://dx.doi.org/10.1038/cddiscovery.2017.33

Ejemplares similares